Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery
NCT ID: NCT06112509
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2024-02-20
2024-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vestibular Evaluation After Vestibular Schwannoma Treatment
NCT03670589
Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma
NCT05641441
Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma
NCT04859335
Cyberknife Radiosurgery for Patients With Neurinomas
NCT02055859
Stereotactic Radiation in Vestibular Schwannoma
NCT01449604
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main symptoms related to the development of vestibular schwannoma are unilateral deafness of perception, unilateral tinnitus, unilateral vestibular deficit vertigo, facial paralysis.
Management is divided into 3 options: monitoring, surgery and gamma-knife radiosurgery.
This study will focus on gamma-knife radiosurgery. The objective of this treatment is to stabilize the evolution of schwannoma.
This study aims to describe the vestibular effects of radiosurgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Radiosurgery
Vestibular exam
Interrogation, videonystagmoscopy, videonystagmography, video-head-impulse-test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vestibular exam
Interrogation, videonystagmoscopy, videonystagmography, video-head-impulse-test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject who benefited from gamma-knife radiosurgery as part of the treatment of vestibular schwannoma
* Non-opposition of the subject to participate in the study
* Affiliation to a French social security scheme or beneficiary of such a scheme
Exclusion Criteria
* Subject who did not benefit from a vestibular assessment before treatment with gamma-knife radiosurgery
* Legal incapacity or limited legal capacity
* Subject unlikely to cooperate in the study and/or weak cooperation anticipated by the investigator
* Subject without health insurance
* Subject being in the period of exclusion from another study or provided for by the "national volunteer file".
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Besancon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
DAMON Veronique, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de Besançon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Besançon
Besançon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023/823
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.